The suppressive effect of β-glucan on the production of tumor necrosis factor-alpha in BV2 microglial cells

Bioscience, Biotechnology and Biochemistry

Volumn 71, Issue 5, 2007, Pages 1360-1364

  Jung, Kyung Hee ^a   Kim, Mi Ja ^b   Ha, Eunyoung ^a   Kim, Hye Kyung ^c   Kim, Young Ock ^d   Kang, Soon Ah ^e   Chung, Joo Ho ^a   Yim, Sung Vin ^a  

^a Kyung Hee University Hospital   (South Korea)

^b Dongduk Women's University   (South Korea)

^c Hanseo University   (South Korea)

^d National Institute of Crop Science   (South Korea)

^e Seoul University of Venture and Information   (South Korea)

Author keywords

glucan; Lipopolysaccharide (LPS); Nuclear factor kappa B (NF B); Tumor necrosis factor alpha (TNF )

Indexed keywords

CELLS; IMMUNOLOGY; POLYSACCHARIDES; PROTEINS; TUMORS;

ANTI-INFLAMMATORY EFFECTS; IMMUNE SYSTEM; LIPOPOLYSACCHARIDE (LPS); NUCLEAR FACTOR KAPPA B; TUMOR NECROSIS FACTORS;

GENE EXPRESSION;

ANTIINFLAMMATORY AGENT; BETA GLUCAN; FORMAZAN; GLUCOSIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; MTT FORMAZAN; TETRAZOLIUM; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; METABOLISM; MICROGLIA; MOLECULAR WEIGHT; MOUSE; TIME;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BETA-GLUCANS; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FORMAZANS; GLUCOSIDES; LIPOPOLYSACCHARIDES; MICE; MICROGLIA; MOLECULAR WEIGHT; NF-KAPPA B; RNA, MESSENGER; TETRAZOLIUM SALTS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34347373933     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.60608     Document Type: Article

References (23)

1. Carrow, D. J., β-1,3-Glucan as a primary immune activator. Townsend Lett., 8, 86-91 (1996).
2. Brown, G. D., and Gordon, S., Fungal β-glucans and mammalian immunity. Immunity, 19, 311-315 (2003).
3. Nakagawa, Y., Ohno, N., and Murai, T., Supression by candida albicans β-glucan of cytokine release from activated human monocytes and from T cells in the presence of monocytes. J. Infect. Dis., 187, 710-713 (2003).
4. Nameda, S., Saito, M., Miura, N. N., Adachi, Y., and Ohno, N., Effect of nitric oxide on beta-glucan/indomethacin-induced septic shock. Biol. Pharm. Bull., 28, 1254-1258 (2005).
5. Hashimoto, T., Ohno, N., Adachi, Y., and Yadomae, T., Enhanced production of inducible nitric oxide synthase by β-glucans in mice. FEMS Immunol. Med. Microbiol., 19, 131-135 (1997).
6. Wei, D., Williams, D., and Browder, W., Activation of AP-1 and SP1 correlates with wound growth factor gene expression in glucan-treated human fibroblasts. Int. Immunopharmacol., 2, 1163-1172 (2002).
7. Delatte, S. J., Evans, J., Hebra, A., Adamson, W., Othersen, H. B., and Tagge, E. P., Effectiveness of betaglucan collagen for treatment of partial-thickness burns in children. J. Pediatr. Surg., 36, 113-118 (2001).
8. Diluzio, N. R., and Williams, D. L., Protective effect of glucan against systemic Staphylococcus aureus septicemia in normal and leukemic mice. Infect. Immun., 20, 804-810 (1978).
9. Gonzalez-Scarano, F., and Baltuch, G., Microglia as mediators of inflammatory and degenerative diseases. Annu. Rev. Neurosci., 22, 219-240 (1999).
10. Nakajima, K., and Kohsaka, S., Microglia: activation and their significance in the central nervous system. J. Biochem. (Tokyo), 130, 169-175 (2001).
11. Czlonkowska, A., Kurkowska-Jastrzebska, I., Czlonkowski, A., Peter, D., and Stefano, G. B., Immune processes in the pathogenesis of Parkinson's disease: a potential role for microglia and nitric oxide. Med. Sci. Monit., 8, RA165-177 (2002).
12. Barone, F. C., Arvin, B., White, R. F., Miller, A., Webb, C. L., Willette, R. N., Lysko, P. G., and Feuerstein, G. Z., Tumor necrosis factor-alpha: a mediator of focal ischemic brain injury. Stroke, 28, 1233-1244 (1997).
13. Kuprash, D. V., Udalova, I. A., Turetskaya, R. L., Rice, N. R., and Nedospasov, S. A., Conserved kappa B element located downstream of the tumor necrosis factor alpha gene: distinct NF-kappa B binding pattern and enhancer activity in LPS activated murine macrophages. Oncogene, 11, 97-106 (1995).
14. Czop, J. K., and Austen, K. F., Properties of glycans that activate the human alternate complement pathway and interact with human monocytes beta glucan receptors. J. Immunol., 135, 3388-3393 (1985).
15. Thornton, B. P., Vetvicka, V., Pitman, M., Goldman, R. C., and Ross, G. D., β-Glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J. Immunol., 156, 1235-1246 (1996).
16. Kidd, P. M., The use of mushroom glucans and proteoglycans in cancer treatment. Altern. Med. Rev., 5, 4-27 (2000).
17. Kataoka, K., Muta, T., Yamazaki, S., and Takeshige, K., Activation of macrophages by linear (1→3)-B-D-glucans: implications for the recognition of fungi by innate immunity. J. Biol. Chem., 277, 36825-36831 (2002).
18. Czop, J. K., and Kay, J., Isolation and characterization of beta-glucan receptors on human mononuclear phagocytes. J. Exp. Med., 173, 1511-1520 (1991).
19. Sener, G., Toklu, H., Ercan, F., and Erkanli, G., Protective effect of beta-glucan against oxidative organ injury in a rat model of sepsis. Int. Immunopharmacol., 5, 1387-1396 (2005).
20. Brennan, F. M., Maini, R. N., and Feldmann, M., Cytokine expression in chronic inflammatory disease. Br. Med. Bull., 51, 368-384 (1995).
21. Siebenlist, U., Franzoso, G., and Brown, K., Structure, regulation and function of NF-kappa B. Annu. Rev. Cell Biol., 10, 405-455 (1994).
22. Read, M. A., Whitley, M. Z., Williams, A. J., and Collins, T., NF-kappa B and I kappa B alpha: an inducible regulatory system in endothelial activation. J. Exp. Med., 179, 503-512 (1994).
23. Williams, D. L., Ha, T., Li, C., Kalbfleisch, J. H., Laffan, J. J., and Ferguson, D. A., Inhibiting early activation of tissue nuclear factor-κB and nuclear factor interleukin 6 with (1-3)-β-D-glucan increases long-term survival in polymicrobial sepsis. Surgery, 126, 54-65 (1999).